4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Lipid Lowering Therapy
Lipid Lowering Therapy, a crucial component in cardiovascular health, focuses on managing and reducing elevated levels of cholesterol and triglycerides in the bloodstream. This therapeutic approach plays a pivotal role in preventing and mitigating cardiovascular diseases, such as heart attacks and strokes. Often involving medications known as statins, fibrates, or cholesterol absorption inhibitors, Lipid Lowering Therapy aims to regulate lipid levels and promote overall cardiovascular well-being. Alongside lifestyle modifications such as a heart-healthy diet and regular exercise, this therapeutic strategy is instrumental in addressing one of the primary risk factors for cardiovascular complications. Regular monitoring and personalized treatment plans contribute to the effectiveness of Lipid Lowering Therapy, underscoring its significance in the comprehensive management of cardiovascular health.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Sana Tariq
Manchester University NHS Foundation Trust, United Kingdom
Achi Kamaraj
Royal Brisbane and Women’s Hospital, Austria
Agustin Joison
Cordoba Catholic University, ArgentinaSubmit your abstract Today
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom